Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine
D Christiansen, L Earnest-Silveira, B Chua, P Meuleman, I Boo, B Grubor-Bauk, DC Jackson, ZY Keck, SKH Foung, HE Drummer, EJ Gowans, J Torresi
Scientific Reports | NATURE PUBLISHING GROUP | Published : 2018
Awarded by National Health and Medical Research Council (NHMRC) of Australia
Awarded by National Institute of Allergy and Infectious Diseases/NIH
Awarded by NHMRC
This work was supported by the National Health and Medical Research Council (NHMRC) of Australia, grant numbers 1060436 and 1126379 and National Institute of Allergy and Infectious Diseases/NIH grants R21AI26582, U19AI123862 and R01AI132213 to SKHF. JT is supported by an NHMRC Practitioner Fellowship, number 106043. We wish to thank Prof Saumitra Das for having provided the cDNA for the production of the HCV genotype 3a VLP vaccine.